NEW YORK (GenomeWeb) – Rosetta Genomics today announced that it has signed a deal to promote Precipio Diagnostics' oncology tests in certain US states, with plans to expand nationally later on.

Through a network of collaborations with Yale School and Medicine and other academic institutes, New Haven, Conn.-based Precipio offers a suite of molecular diagnostics that it tailors to patients' disease based on pathology and symptoms.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.